뉴스레터 구독 서비스를 등록하시면 당사 뉴스룸에서 제공되는
삼성바이오로직스의 최신 소식과 관심 분야별 유용한 정보를 받아 보실 수 있습니다.
Your valuable comments contribute to protecting Samsung Biologic’s core technology and management information, as well as reinforcing domestic competency and economic development.
-Samsung Biologics and STCube Enter into Development and Manufacturing Agreement for Novel Target Anticancer Drug
more-Naming Biopharmaceutical Products 1 Monoclonal Antibody Drugs
more-Naming Biopharmaceutical Products 1 Monoclonal Antibody Drugs
moreCopyright Samsung Biologics. All rights reserved